Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
City of Hope Medical Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Tongji Hospital
Institut National de la Santé Et de la Recherche Médicale, France
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)